MDxHealth SA

General ticker "MDXH" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $120.4M (TTM average)

MDxHealth SA follows the US Stock Market performance with the rate: 56.5%.

Estimated limits based on current volatility of 2.8%: low 3.55$, high 3.76$

Factors to consider:

  • Total employees count: 191 as of 2021
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [1.65$, 3.77$]
  • 2025-12-31 to 2026-12-31 estimated range: [1.70$, 3.88$]

Financial Metrics affecting the MDXH estimates:

  • Positive: with PPE of -1.9 at the end of fiscal year the price was low
  • Negative: negative Operating income
  • Negative: Operating cash flow per share per price, % of -17.01 <= 0.33
  • Positive: Industry inventory ratio change (median), % of -0.79 <= -0.15

Similar symbols

Short-term MDXH quotes

Long-term MDXH plot with estimates

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $37.05MM $70.19MM $90.05MM
Operating Expenses $74.95MM $97.52MM $114.77MM
Operating Income $-37.90MM $-27.33MM $-24.72MM
Non-Operating Income $-6.14MM $-15.77MM $-12.96MM
Interest Expense $2.74MM $5.77MM $7.63MM
R&D Expense $7.56MM $6.38MM $10.55MM
Income(Loss) $-44.04MM $-43.10MM $-37.69MM
Taxes $0.00MM $0.00MM $0.38MM
Profit(Loss)* $-50.19MM $-58.87MM $-51.42MM
Stockholders Equity $9.31MM $7.21MM $14.84MM
Inventory $2.33MM $2.78MM $3.87MM
Assets $119.14MM $129.13MM $157.33MM
Operating Cash Flow $-34.12MM $-21.50MM $-18.53MM
Capital expenditure $4.16MM $5.02MM $2.16MM
Investing Cash Flow $-29.04MM $-3.93MM $-1.64MM
Financing Cash Flow $20.72MM $32.28MM $44.60MM
Earnings Per Share** $-3.16 $-2.27 $-1.06

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.